Experimental nickel elicitation thresholds--a review focusing on occluded nickel exposure.
Nickel (Ni) is the most frequent cause of contact allergy among the female population. This makes it interesting to examine thresholds for elicitation under different conditions. Even though Ni exposure may be open, occluded, penetrating or oral, most dose-response studies in the literature concern single occluded application. The aims of this study were to assess thresholds of response by making a statistical analysis of available dose-response studies with single occluded exposure and comparing the results to thresholds from other modes of exposure. 8 occluded Ni dose-response studies were selected based on statistical considerations. The statistical analysis showed that 5% of a sensitized population react to 0.44 microg Ni/cm2 and 10% react to 1.04 microg Ni/cm2. In another study with a single open application, 7.8% of sensitized persons responded to a dose x6 higher than the dose to which 10% reacted in occluded exposure. When combining the exposure to Ni with an irritant, divagating results were found, although the literature shows evidence of an augmented response when combining exposure to an allergen and an irritant. The thresholds of penetrating exposure were found to be lower than the thresholds of single occluded exposure. Comparisons of different kind of exposures across studies are difficult, because of differences in the studies, although a comparison could be made by a study that compares the different exposures within the same individuals at the same time.
Fischer
Louise Arup
LA
National Allergy Research Centre, Gentofte Hospital, University of Copenhagen, Gentofte, Denmark. loarfi01@gentoftehosp.kbhamt.dk
Menné
Torkil
T
Johansen
Jeanne Duus
JD
D000485:Allergens / Q000008:administration & dosage* / Q000009:adverse effects; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009532:Nickel / Q000008:administration & dosage* / Q000009:adverse effects; D019055:No-Observed-Adverse-Effect Level; D010328:Patch Tests; D012867:Skin / Q000187:drug effects*
D000485:Allergens; D009532:Nickel